Loading...

LXRX LEXICON PHARMACEUTICALS INC Earnings Reports 8-K Filing

LXCN

LXRX

LEXICON PHARMACEUTICALS INC

(LXRX)

2025 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Earnings Report

Filing with Quantitative Data

Filing with Quantitative Data

Filing with Quantitative Data

Capital Structure Change

Private Placement

Contract Renewal

Quantitative Data

External Links:

Lexicon Pharmaceuticals Inc reported a net loss of $10.4 million for the third quarter of 2023, with total revenue of $1.2 million, primarily from collaborations and grants.

AI Assistant

LEXICON PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.